Neuroprotective potentials of candesartan, atorvastatin and their combination against stroke induced motor dysfunction

Inflammopharmacology

Volumn 19, Issue 4, 2011, Pages 205-214

  Gaur, Vaibhav ^a   Kumar, Anil ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Atorvastatin; Candesartan; Mitochondrial dysfunction; Oxidative stress; Stroke

Indexed keywords

ATORVASTATIN; CANDESARTAN; CATALASE; CYTOCHROME C OXIDASE; GLUTATHIONE TRANSFERASE; MALONALDEHYDE; NITRITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE DISMUTASE; UBIQUINOL CYTOCHROME C REDUCTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; COMBINATION CHEMOTHERAPY; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVITY; HIPPOCAMPUS; IN VIVO STUDY; LOCOMOTION; MALE; MONOTHERAPY; MOTOR DYSFUNCTION; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; ROTAROD TEST; STROKE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BEHAVIOR, ANIMAL; BENZIMIDAZOLES; BRAIN; BRAIN ISCHEMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MITOCHONDRIA; MOTOR ACTIVITY; MOVEMENT DISORDERS; NEURONS; ORGAN SPECIFICITY; OXIDATIVE STRESS; PYRROLES; RANDOM ALLOCATION; RATS; RATS, WISTAR; REPERFUSION INJURY; STROKE; TETRAZOLES;

EID: 79960202430     PISSN: 09254692     EISSN: 15685608     Source Type: Journal    
DOI: 10.1007/s10787-010-0068-y     Document Type: Article

References (59)

1. T Abe N Takagi M Nakano S Takeo 2004 The effects of monobromobimane on neuronal cell death in the hippocampus after transient global cerebral ischemia in rats Neurosci Lett 357 3 227 231 15003291 10.1016/j.neulet.2003.12.088 1:CAS:528:DC%2BD2cXhslWntrw%3D (Pubitemid 38299264)
2. A Aggarwal V Gaur A Kumar 2010 Nitric oxide mechanism in the protective effect of naringin against post-stroke depression (PSD) in mice Life Sci 86 1 928 935 20433854 10.1016/j.lfs.2010.04.011 1:CAS:528:DC%2BC3cXntVegt7s%3D
3. Awad AS (2010) Effect of Combined Treatment With Curcumin and Candesartan on Ischemic Brain Damage in Mice. J Stroke Cerebrovasc Dis (in press)
4. K Baker CB Marcus K Huffman H Kruk B Malfroy SR Doctrow 1998 Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: a key role for reactive oxygen species in ischemic brain injury J Pharmacol Exp Ther 284 1 215 221 9435181 1:CAS:528:DyaK1cXltlCktg%3D%3D (Pubitemid 28109549)
5. SB Berman TG Hastings 1999 Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease J Neurochem 73 3 1127 1137 10461904 10.1046/j.1471-4159.1999.0731127.x 1:CAS:528:DyaK1MXlsVOitL4%3D (Pubitemid 29395471)
6. BH Bland CH Vanderwolf 1972 Diencephalic and hippocampal mechanisms of motor activity in the rat: effects of posterior hypothalamic stimulation on behavior and hippocampal slow wave activity Brain Res 43 1 67 88 5050203 10.1016/0006-8993(72)90275-2 1:STN:280:DyaE383ltlaktg%3D%3D
7. SP Butcher R Bullock DI Graham J McCulloch 1990 Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion Stroke 21 12 1727 1733 2264080 10.1161/01.STR.21.12.1727 1:CAS:528:DyaK3MXitVCqtLo%3D
8. S Carloni E Mazzoni M Cimino MG De Simoni C Perego C Scopa W Balduini 2006 Simvastatin reduces caspase-3 activation and inflammatory markers induced by hypoxia-ischemia in the newborn rat Neurobiol Dis 21 1 119 126 16054375 10.1016/j.nbd.2005.06.014 1:CAS:528:DC%2BD2MXhtlCkt7nP (Pubitemid 41817312)
9. G Chaudhary U Sharma NR Jagannathan YK Gupta 2003 Evaluation of Withania somnifera in a middle cerebral artery occlusion model of stroke in rats Clin Exp Pharmacol Physiol 30 5-6 399 404 12859433 10.1046/j.1440-1681.2003.03849.x 1:CAS:528:DC%2BD3sXkslaitLg%3D (Pubitemid 36713999)
10. L Cui X Zhang R Yang L Wang L Liu M Li W Du 2010 Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability Brain Res 1325 164 173 20167207 10.1016/j.brainres.2010.02.036 1:CAS:528:DC%2BC3cXktlGnsbY%3D
11. WJ Dai A Funk T Herdegen T Unger J Culman 1999 Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats Stroke 30 11 2391 2398 10548676 10.1161/01.STR.30.11.2391 1:CAS:528:DyaK1MXnsFSltL0%3D discussion 2398-2399
12. BH Dobkin 1991 The rehabilitation of elderly stroke patients Clin Geriatr Med 7 3 507 523 1868408 1:STN:280:DyaK3MzjtVSrtQ%3D%3D
13. T Engelhorn S Goerike A Doerfler C Okorn M Forsting G Heusch R Schulz 2004 The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats J Cereb Blood Flow Metab 24 4 467 474 15087716 10.1097/00004647-200404000-00012 (Pubitemid 38455442)
14. A Ferrara S El Bejaoui S Seyen E Tirelli JC Plumier 2009 The usefulness of operant conditioning procedures to assess long-lasting deficits following transient focal ischemia in mice Behav Brain Res 205 2 525 534 19686784 10.1016/j.bbr.2009.08.011
15. V Gaur A Kumar 2010 Behavioral, biochemical and cellular correlates in the protective effect of sertraline against transient global ischemia induced behavioral despair: Possible involvement of nitric oxide-cyclic guanosine monophosphate study pathway Brain Res Bull 82 1 57 64 20123004 10.1016/j.brainresbull.2010.01.010 1:CAS:528:DC%2BC3cXlsFaju7s%3D
16. V Gaur A Kumar 2010 Possible involvement of l-arginine-nitric oxide signaling pathway in protective effect of hesperidin against ischemic reperfusion cerebral injury induced memory dysfunction Pharmacol Rep 62 4 635 648 20885004 1:CAS:528:DC%2BC3MXitFGju7Y%3D
17. Gaur V, Kumar A (2010c) Protective effect of desipramine, venlafaxine and trazodone against experimental animal model of transient global ischemia: possible involvement of NO-cGMP pathway. Brain Res 1353:204-212
18. V Gaur A Aggarwal A Kumar 2009 Protective effect of naringin against ischemic reperfusion cerebral injury: possible neurobehavioral, biochemical and cellular alterations in rat brain Eur J Pharmacol 616 1-3 147 154 19577560 10.1016/j.ejphar.2009.06.056 1:CAS:528:DC%2BD1MXptlans7s%3D
19. AG Gornall CJ Bardawill MM David 1949 Determination of serum proteins by means of the biuret reaction J Biol Chem 177 2 751 766 18110453 1:STN:280:DyaH1M%2Fht1Snuw%3D%3D
20. LC Green DA Wagner J Glogowski PL Skipper JS Wishnok SR Tannenbaum 1982 Analysis of nitrate, nitrite, and [15 N]nitrate in biological fluids Anal Biochem 126 1 131 138 7181105 10.1016/0003-2697(82)90118-X 1:CAS:528: DyaL38XlvFGgtLY%3D (Pubitemid 13203451)
21. W Groth A Blume P Gohlke T Unger J Culman 2003 Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats J Hypertens 21 11 2175 2182 14597862 10.1097/00004872-200311000-00028 1:CAS:528: DC%2BD3sXos1amu70%3D (Pubitemid 38296880)
22. B Halliwell 1992 Reactive oxygen species and the central nervous system J Neurochem 59 5 1609 1623 1402908 10.1111/j.1471-4159.1992.tb10990.x 1:CAS:528:DyaK38XmsVKlsbk%3D
23. H Hong JS Zeng DL Kreulen DI Kaufman AF Chen 2006 Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke Am J Physiol Heart Circ Physiol 291 5 H2210 H2215 16766636 10.1152/ajpheart.01270.2005 1:CAS:528:DC%2BD28Xht1GnsLbE
24. N Hosomi K Mizushige M Kitadai H Ohyama SI Ichihara T Takahashi H Matsuo 1999 Induced hypertension treatment to improve cerebral ischemic injury after transient forebrain ischemia Brain Res 835 2 188 196 10415373 10.1016/S0006-8993(99)01577-2 1:CAS:528:DyaK1MXktlyitbk%3D (Pubitemid 29343780)
25. T Ide H Tsutsui S Hayashidani D Kang N Suematsu K Nakamura H Utsumi N Hamasaki A Takeshita 2001 Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction Circ Res 88 5 529 535 11249877 1:CAS:528:DC%2BD3MXit1Cqt7o%3D (Pubitemid 32240917)
26. LW Jenkins JT Povlishock W Lewelt JD Miller DP Becker 1981 The role of postischemic recirculation in the development of ischemic neuronal injury following complete cerebral ischemia Acta Neuropathol 55 3 205 220 7349579 10.1007/BF00691320 1:STN:280:DyaL3s7it12qtg%3D%3D (Pubitemid 12240162)
27. J Jingtao S Sato N Yamanaka 1999 Changes in cerebral blood flow and blood brain barrier in the gerbil hippocampal CA1 region following repeated brief cerebral ischemia Med Electron Microsc 32 3 175 183 11810442 10.1007/s007950050025 (Pubitemid 30182206)
28. K Karki RA Knight Y Han D Yang J Zhang KA Ledbetter M Chopp DM Seyfried 2009 Simvastatin and atorvastatin improve neurological outcome after experimental intracerebral hemorrhage Stroke 40 10 3384 3389 19644071 10.1161/STROKEAHA.108.544395 1:CAS:528:DC%2BD1MXhtFGjsb7K
29. TE King 1967 Preparation of succinate dehydrogenase and reconstitution of succinate oxidase Method Enzymol 10 322 331 10.1016/0076-6879(67)10061-X 1:CAS:528:DyaF1MXlsVamtA%3D%3D
30. TE King RL Howard 1967 Preparation and properties of soluble NADH dehydrogenase from cardiac muscle Method Enzymol 10 275 294 10.1016/0076- 6879(67)10055-4 1:CAS:528:DyaF1MXnsVGitA%3D%3D
31. Y Kono 1978 Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase Arch Biochem Biophys 186 1 189 195 24422 10.1016/0003-9861(78)90479-4 1:CAS:528:DyaE1cXhtFKrsr0%3D (Pubitemid 8290500)
32. Kulkarni SK (1999) Handbook of experimental pharmacology. Vallabh Prakashan, Delhi, pp 117-119
33. A Kumar R Garg V Gaur P Kumar 2010 Venlafaxine involves nitric oxide modulatory mechanism in experimental model of chronic behavior despair in mice Brain Res 1311 73 80 19945444 10.1016/j.brainres.2009.11.050 1:CAS:528:DC%2BC3cXot1Cj
34. W Landau 2009 Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack Neurology 73 10 817 19738180 10.1212/WNL.0b013e3181b77160 author reply 818
35. ST Lee K Chu JE Park NH Hong WS Im L Kang Z Han KH Jung MW Kim M Kim 2008 Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways J Neurochem 104 5 1190 1200 17976163 10.1111/j.1471-4159.2007.05044.x 1:CAS:528: DC%2BD1cXjtFCnt7k%3D (Pubitemid 351293333)
36. G Lenaz 1998 Role of mitochondria in oxidative stress and ageing Biochim Biophys Acta 1366 1-2 53 67 9714734 1:CAS:528:DyaK1cXltFWksL8%3D (Pubitemid 28467022)
37. A Lewen P Matz PH Chan 2000 Free radical pathways in CNS injury J Neurotrauma 17 10 871 890 11063054 10.1089/neu.2000.17.871 1:STN:280: DC%2BD3crgvFOjtA%3D%3D
38. JK Liao U Laufs 2005 Pleiotropic effects of statins Annu Rev Pharmacol Toxicol 45 1 89 118 15822172 10.1146/annurev.pharmtox.45.120403.095748 1:CAS:528:DC%2BD2MXisVWjtrY%3D (Pubitemid 40261799)
39. Y Liu DA Peterson H Kimura D Schubert 1997 Mechanism of cellular 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction J Neurochem 69 2 581 593 9231715 10.1046/j.1471-4159.1997.69020581.x 1:CAS:528:DyaK2sXkvFGktb0%3D (Pubitemid 27327958)
40. Luck H (1971) Catalase, methods of enzymatic analysis. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Academic Press, New York, pp 885-893
41. WH Miltner H Bauder M Sommer C Dettmers E Taub 1999 Effects of constraint-induced movement therapy on patients with chronic motor deficits after stroke: a replication Stroke 30 3 586 592 10066856 10.1161/01.STR.30.3.586 1:STN:280:DyaK1M7mslKgsw%3D%3D (Pubitemid 29115396)
42. RW Neumar 2000 Molecular mechanisms of ischemic neuronal injury Ann Emerg Med 36 5 483 506 11054204 1:STN:280:DC%2BD3M%2FmvVCisQ%3D%3D
43. Y Nishimura T Ito K Hoe JM Saavedra 2000 Chronic peripheral administration of the angiotensin II AT(1) receptor antagonist candesartan blocks brain AT(1) receptors Brain Res 871 1 29 38 10882779 10.1016/S0006- 8993(00)02377-5 1:CAS:528:DC%2BD3cXksFGjurc%3D (Pubitemid 30406864)
44. S Patassini C Giampa A Martorana G Bernardi FR Fusco 2008 Effects of simvastatin on neuroprotection and modulation of Bcl-2 and BAX in the rat quinolinic acid model of Huntington's disease Neurosci Lett 448 1 166 169 18938217 10.1016/j.neulet.2008.10.023 1:CAS:528:DC%2BD1cXhtlyiurnF
45. P Racay M Chomova Z Tatarkova P Kaplan J Hatok D Dobrota 2009 Ischemia-induced mitochondrial apoptosis is significantly attenuated by ischemic preconditioning Cell Mol Neurobiol 29 6-7 901 908 19283470 10.1007/s10571-009- 9373-7 1:CAS:528:DC%2BD1MXptFCksrw%3D
46. MA Saad AM Abbas V Boshra M Elkhateeb IA El Aal 2010 Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke Acta Physiol Hung 97 2 159 171 20511125 10.1556/APhysiol.97.2010.2.2 1:CAS:528:DC%2BC3cXos1Siu7k%3D
47. JM Saavedra 1992 Brain and pituitary angiotensin Endocr Rev 13 2 329 380 1618166 1:CAS:528:DyaK38XltVCgs7g%3D
48. K Schmerbach JH Schefe M Krikov S Muller A Villringer U Kintscher T Unger C Thoene-Reineke 2008 Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain Brain Res 1208 225 233 18378216 10.1016/j.brainres.2008.02.032 1:CAS:528:DC%2BD1cXlsFOjt78%3D
49. GL Sottocasa B Kuylenstierna L Ernster A Bergstrand 1967 An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study J Cell Biol 32 2 415 438 10976232 10.1083/jcb.32.2.415 1:CAS:528:DyaF2sXot1CjsQ%3D%3D
50. N Tanahashi Y Fukuuchi 2002 Treatment of acute ischemic stroke: recent progress Intern Med 41 5 337 344 12058880 10.2169/internalmedicine.41.337 (Pubitemid 34746175)
51. UI Tuor MH Kondysar RK Harding 1988 Effect of angiotensin II and peptide YY on cerebral and circumventricular blood flow Peptides 9 1 141 149 3362742 10.1016/0196-9781(88)90020-4 1:CAS:528:DyaL1cXhsVCitLk%3D (Pubitemid 18070141)
52. PJ van der Most AM Dolga IM Nijholt PG Luiten UL Eisel 2009 Statins: mechanisms of neuroprotection Prog Neurobiol 88 1 64 75 19428962 10.1016/j.pneurobio.2009.02.002
53. CJ Vaughan N Delanty 1999 Neuroprotective properties of statins in cerebral ischemia and stroke Stroke 30 9 1969 1973 10471452 10.1161/01.STR.30.9. 1969 1:CAS:528:DyaK1MXmtFKlsrw%3D (Pubitemid 29411843)
54. L Wang X Zhang L Liu R Yang L Cui M Li 2010 Atorvastatin protects rat brains against permanent focal ischemia and downregulates HMGB1, HMGB1 receptors (RAGE and TLR4), NF-kappaB expression Neurosci Lett 471 3 152 156 20100543 10.1016/j.neulet.2010.01.030 1:CAS:528:DC%2BC3cXit1OmsL4%3D
55. ED Wills 1966 Mechanisms of lipid peroxide formation in animal tissues Biochem J 99 3 667 676 5964963 1:CAS:528:DyaF28XhtVKis7k%3D
56. Y Yamamoto N Shioda F Han S Moriguchi A Nakajima A Yokosuka Y Mimaki Y Sashida T Yamakuni Y Ohizumi K Fukunaga 2009 Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation Brain Res 1295 218 229 19646972 10.1016/j.brainres.2009.07. 081 1:CAS:528:DC%2BD1MXhtFyqsb7P
57. S Yanpallewar S Rai M Kumar S Chauhan SB Acharya 2005 Neuroprotective effect of Azadirachta indica on cerebral post-ischemic reperfusion and hypoperfusion in rats Life Sci 76 12 1325 1338 15670613 10.1016/j.lfs.2004.06. 029 1:CAS:528:DC%2BD2MXntVSktg%3D%3D
58. J Yrjanheikki J Koistinaho M Kettunen RA Kauppinen K Appel M Hull BL Fiebich 2005 Long-term protective effect of atorvastatin in permanent focal cerebral ischemia Brain Res 1052 2 174 179 16023089 10.1016/j.brainres.2005.06. 004 (Pubitemid 41116775)
59. J Zhou J Pavel M Macova ZX Yu H Imboden L Ge T Nishioku J Dou E Delgiacco JM Saavedra 2006 AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats Stroke 37 5 1271 1276 16601219 10.1161/01.STR.0000217404.64352.d7 1:CAS:528: DC%2BD28XjsFahtrg%3D (Pubitemid 43731875)